Organizing Committee
- Giuseppe Cornaglia, Verona, IT
- Javier Garau, Barcelona, ES
- Jordi Vila, Barcelona, ES
Conference Objectives
- Deliver insights into P. aeruginosa virulence factors
- Introduce the different mechanisms of antibiotic resistance in this species
- Update on the epidemiology of nosocomial P. aeruginosa infections
- Present advances in the management of P. aeruginosa infections in structural lung disease and in the mechanically ventilated patient
- Discuss present and future options in the treatment of multiply resistant P. aeruginosa
Target Audience
All scientists interested in Pseudomonas aeruginosa from the virulence to clinical aspects are invited to attend. This conference especially gives young scientists the possibility for in-depth discussion with senior colleagues.
Basic Microbiology
- Genomic analysis and virulence in P. aeruginosa
Stephen Lory - Interplay between P. aeruginosa and host epithelial cells
Gerald Pier - Role of the efflux pumps on the virulence
José Luis Martinez - Discussion
Antibiotic resistance
- Types and prevalence
Jordi Vila - Molecular basis of the AmpC hyperproduction: clinical implications
Antonio Oliver - Carbapenem resistance
Gian Maria Rossolini - Discussion
- The outer membrane barrier and its role in the intrinsic resistance
Luis Martínez-Martínez - Clinical implications of efflux pumps in P. aeruginosa
Patrick Plesiat - Antibiotic-mediated adaptive responses in P. aeruginosa
Jésus Blázquez - Discussion
Epidemiology and selected clinical aspects I
- P. aeruginosa infections and the 21st Century
Giuseppe Cornaglia - Multi-drug resistant P. aeruginosa: risk factors and clinical impact
Yehuda Carmeli - Nosocomial outbreaks of P. aeruginosa: detection, dynamics and control
Murat Akova - P. aeruginosa bone and joint infections: a reappraisal
Helen Giamarellou
Selected clinical aspects II: Cystic fibrosis
- Transcriptomics and biofilm formation
Richard D. Waite - Inhibition of quorum sensing as a potential antivirulence target
Niels Høiby - Management of colonisation by P. aeruginosa in cystic fibrosis
Gerd Döring - Discussion
Selected clinical aspects III: COPD and mechanical ventilation
- P. aeruginosa VAP: the problem and modern management
Jean Chastre - P. aeruginosa and advanced COPD: colonisation vs. infection
Antonio Torres - Development and persistence of antimicrobial resistance in P. aeruginosa infections
Thilo Köhler - Discussion
